阿里拉姆制药 ALNY 深 沪
已收盘 05-08 16:00:00 美东时间
295.05
-0.860
-0.29%
华盛通- 最 高300.17
- 今 开295.91
- 成交量 92.68万股
- 最 低 293.06
- 昨 收 295.91
- 总市值 393.93亿
- 52周最高 495.55
- 市盈率 静 126.66
- 换手率 0.69%
- 52周最低 284.19
- 委 比 32.31%
- 总股本 1.34亿
- 历史最高 495.55
- 量 比 0.81
- 振 幅 2.40%
- 历史最低 5.879
- 每 手 1
- 风险率 65.88%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ClearBridge Large Cap Growth adds, and exits multiple positions in Q1
ClearBridge’s Large Cap Growth ESG Strategy outperformed its Russell 1000 Growth Index benchmark in Q1 2026, as the broader market sell-off driven by Middle East tensions pushed the S&P 500 down 4.3% ...
05-08 01:40
MBX Biosciences Announces Appointment of Mark Soued as Chief Commercial Officer and Inducement Grant Award
MBX Biosciences appoints Mark R. Soued, MBA, as Chief Commercial Officer. With over 20 years of experience in global biopharmaceuticals, Soued brings expertise in product launches, market access, and commercial team building. He previously led US amyloidosis business at Alnylam and held senior roles at Pfizer. MBX granted Soued an equity award as part of his appointment.
05-07 11:00
美股大行评级 | 苹果获多家机构上调目标价，最高至335美元；闪迪获华尔街大行看多至2000美元
今日重点评级关注：Benchmark：维持史密斯微软件"买入"评级，目标价从2美元升至2.5美元；Citizens：维持DBV Technologies"跑赢大市"评级，目标价从47美元升至55美元
05-04 16:04
财报速睇 | 阿里拉姆制药 2026财年Q1营收11.67亿美元，同比增长96.5%；归母净利润2.06亿美元，扭亏为盈
华盛资讯4月30日讯，阿里拉姆制药公布2026财年Q1业绩，公司Q1营收11.67亿美元，同比增长96.5%，归母净利润2.06亿美元，扭亏为盈。
04-30 20:52
Alnylam Pharmaceuticals Affirms FY2026 Sales Guidance of $5.300B-$5.800B vs $5.545B Est
Alnylam Pharmaceuticals (NASDAQ:ALNY) affirms FY2026 sales outlook from $5.300 billion-$5.800 billion to $5.300 billion-$5.800 billion vs $5.545 billion estimate.
04-30 20:34
财报速睇 | 阿里拉姆制药 2026财年Q1营收11.67亿美元，同比增长96.5%；归母净利润2.06亿美元，扭亏为盈
华盛资讯4月30日讯，阿里拉姆制药公布2026财年Q1业绩，公司Q1营收11.67亿美元，同比增长96.5%，归母净利润2.06亿美元，扭亏为盈。
04-30 20:24
Alnylam Pharmaceuticals Q1 Adj. EPS $1.99 Beats $0.93 Estimate, Sales $1.167B Beat $1.114B Estimate
Alnylam Pharmaceuticals (NASDAQ:ALNY) reported quarterly earnings of $1.99 per share which beat the analyst consensus estimate of $0.93 by 113.98 percent. This is a 586.21 percent increase over earnings of $0.29 per
04-30 20:01
Earnings Scheduled For April 30, 2026
Companies Reporting Before The Bell • Sonic Automotive (NYSE:SAH) is projected ...
04-30 19:11
Codexis To Present New Data And Provide Regulatory Update On ECO Synthesis Manufacturing Platform At TIDES USA May 11-14
Codexis' technical experts will present at three sessions during the conference:Spotlight Presentation:Controlling Phosphorothioate Stereochemistry: Challenges and Innovations in Oligonucleotide ManufacturingStefan Lutz,
04-29 21:03
Here's How Much $1000 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth Today
Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past...
04-21 23:15
